Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

BACKGROUND: Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in advanced stages ovarian cancer with respect to the TP53...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Felisiak-Golabek, Anna, Rembiszewska, Alina, Rzepecka, Iwona K, Szafron, Lukasz, Madry, Radoslaw, Murawska, Magdalena, Napiorkowski, Tomasz, Sobiczewski, Piotr, Osuch, Beata, Kupryjanczyk, Jolanta
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223127/
https://ncbi.nlm.nih.gov/pubmed/22075440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-4-20
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires